Drug Shortage Report for SANDOZ ATORVASTATIN

Last updated on 2023-04-12 History
Report ID 177917
Drug Identification Number 02324970
Brand name SANDOZ ATORVASTATIN
Common or Proper name ATORVASTATIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ATORVASTATIN
Strength(s) 80MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100FCT
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-12-12
Estimated end date 2023-04-28
Actual end date 2023-04-11
Shortage status Resolved
Updated date 2023-04-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-12-12 English Compare
v2 2022-12-12 French Compare
v3 2022-12-13 English Compare
v4 2023-03-13 English Compare
v5 2023-03-13 French Compare
v6 2023-04-11 English Compare
v7 2023-04-11 French Compare
v8 2023-04-12 English Compare

Showing 1 to 8 of 8